Pain News and Research

Latest Pain News and Research

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, announced today that it has begun distributing and selling Cobroxin through mass food and drug retail chains in the Northeast, Southeast, Middle Atlantic and Midwest regions.

12 Feb 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage procedures for victims of the recent natural disasters in Haiti.

12 Feb 2010

iTech Medical signs manufacturing agreement with Thought Technology for MPR technology

iTech Medical, an information technology company, announced today that it has signed an exclusive, three-year manufacturing agreement with Thought Technology Ltd. of Montreal, Quebec for the Company’s proprietary Muscle Pattern Recognition (MPR) technology.

12 Feb 2010

Mayo Clinic provides treatment options for aging skin

Age or liver spots -- These flat, brown areas, also called solar lentigos, typically occur on the hands, back and face. Using a topical retinoid -- often in conjunction with bleaching cream and a mild topical steroid -- may gradually fade an age spot.

11 Feb 2010

Alcon reports 2009 fourth quarter results

Alcon, Inc. reported that global sales rose 14.5 percent to $1.72 billion for the fourth quarter of 2009, or an 8.5 percent increase excluding the impact of foreign exchange fluctuations. Reported net earnings for the fourth quarter of 2009 grew 8.0 percent to $458 million, or $1.51 per diluted share.

11 Feb 2010

Cognitive behavioral therapy effective for insomnia and chronic pain

Cognitive behavioral therapy for insomnia significantly improved sleep for patients with chronic neck or back pain and also reduced the extent to which pain interfered with their daily functioning, according to a study by University of Rochester Medical Center researchers.

11 Feb 2010

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

Cadence Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for intravenous (IV) acetaminophen.

11 Feb 2010

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

Massachusetts primary care physicians continue to achieve measurable improvements in important aspects of health care quality as reported by Massachusetts Health Quality Partners (MHQP). Today, the organization released its sixth annual Quality Insights: Clinical Quality in Primary Care report, comparing the performance of more than 150 medical groups across the state.

11 Feb 2010

Neurotoxin study may help find new therapies to block hyperactive ion channels

There are approximately 500 species of cone snails, each producing 50 - 200 different conotoxins. A similar number of peptide toxins are produced by snakes, spiders, sea anemones, scorpions and other venomous animals. The animals use the neurotoxins to paralyze their prey.

11 Feb 2010

Sermo physician community discusses refusal to accept Medicare pricing

Sermo, the world's largest online community for physicians, today announced its weekly hot topic. More than 500 physicians participated in a Sermo post "FTC - Refusal to accept Medicare pricing = Price Fixing." The discussion focuses on a complaint from the FTC that the Roaring Fork Valley Physicians IPA, by refusing to accept Medicare price controls, violated anti-trust laws. The announcement prompted strong reaction among many physicians who argue they should be able to accept or decline payment terms, like any other profession.

11 Feb 2010

McKesson releases latest version of Lytec EHR and practice management solutions

To help physician practices improve workflow, cash flow and patient care, McKesson has released the latest and fastest versions of its trusted Lytec® electronic health record (EHR) and practice management solutions, used by thousands of doctors nationwide. The updated Lytec® MD is a seamlessly combined CCHIT-certified EHR and practice management system that features Bright Note Technology™, a proprietary chart automation function. It also features Lytec® Connect, designed to enable the secure electronic delivery of patient data across care settings.

11 Feb 2010

Women's heart-health awareness: Educational campaigns with evidence-based prevention messages needed

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

11 Feb 2010

Silver nanoparticles in higher-power, longer-life batteries for ICDs

Diamonds and gold may make some hearts flutter on Valentine's Day, but in a University at Buffalo laboratory, silver nanoparticles are being designed to do just the opposite.

11 Feb 2010

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

QRxPharma Limited announced today initiation of its second pivotal Phase 3 registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo™IR, a patented 3:2 ratio fixed dose combination of morphine plus oxycodone.

11 Feb 2010

Exeter Hospital designated as 'Blue Distinction Center for Knee and Hip Replacement'

Citing clinical expertise and quality of care, Anthem Blue Cross and Blue Shield in New Hampshire has designated Exeter Hospital as a Blue Distinction Center for Knee and Hip Replacement(SM).

11 Feb 2010

Trimel BioPharma Holdings updates business developments

Trimel BioPharma Holdings Inc. is today providing an update on a number of operational items that have contributed significantly to advancing the Company and achieving its initial objectives.

10 Feb 2010

AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA

AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).

10 Feb 2010

Top ten myths about sex

Boston Medical Group, a national physician network specializing in the treatment of erectile dysfunction and premature ejaculation, today released ten of the top myths surrounding sex. From which gender spends the most time fantasizing to whether size really matters, the list covers some of the common misconceptions about time spent between the sheets.

10 Feb 2010

YM BioSciences receives additional AeroLEF patents in U.S.

YM BioSciences Inc., announced that it has been granted two additional patents in the US for AeroLEF(R), the Company's proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe acute pain. US patent numbers 7,648,981 and 7,648,982 extend the life of YM's AeroLEF patent estate in the US to 2024.

10 Feb 2010

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".

10 Feb 2010

Pain News and Research

Latest Pain News and Research

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

iTech Medical signs manufacturing agreement with Thought Technology for MPR technology

Mayo Clinic provides treatment options for aging skin

Alcon reports 2009 fourth quarter results

Cognitive behavioral therapy effective for insomnia and chronic pain

Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter

MHQP: Massachusetts primary care physicians achieve measurable improvements in health care quality

Neurotoxin study may help find new therapies to block hyperactive ion channels

Sermo physician community discusses refusal to accept Medicare pricing

McKesson releases latest version of Lytec EHR and practice management solutions

Women's heart-health awareness: Educational campaigns with evidence-based prevention messages needed

Silver nanoparticles in higher-power, longer-life batteries for ICDs

QRxPharma announces the initiation of second pivotal Phase 3 registration trial of MoxDuo IR

Exeter Hospital designated as 'Blue Distinction Center for Knee and Hip Replacement'

Trimel BioPharma Holdings updates business developments

AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA

Top ten myths about sex

YM BioSciences receives additional AeroLEF patents in U.S.

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in